About Lupin Limited (LUPIN)
Lupin Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India. LUPIN has been publicly traded since 2001, giving it 25+ years of trading history.
Lupin Limited (LUPIN) has been publicly traded since 2001, making it a 25-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Mumbai, India and employs approximately 24,006 people. With a market capitalization of $1.1 trillion, LUPIN is one of the largest publicly traded companies.
LUPIN trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $1.1 trillion. The company employs approximately 24,006 people worldwide.
Key Statistics
- Current Price
- ₹2,314.90
- Market Cap
- ₹1.06T
- 52-Week High
- ₹2,377.60
- 52-Week Low
- ₹1,795.20
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
LUPIN Investment Performance
LUPIN has gained 9.7% year-to-date in 2026. Over the past 5 years, a $1,000 investment in LUPIN would have grown to $2,246, representing a 124.6% total return. Since its IPO in 2001, a $1,000 investment would now be worth $356,458.
₹1,000 Invested in Lupin Limited (LUPIN)
How much would ₹1,000 invested in LUPIN be worth today?
What would ₹1,000 invested in LUPIN 1 year ago be worth today?
A ₹1,000 investment in Lupin Limited (LUPIN) in 2025 would be worth ₹1,147 as of May 2026, representing a +14.7% total return.
What would ₹1,000 invested in LUPIN 3 years ago be worth today?
A ₹1,000 investment in Lupin Limited (LUPIN) in 2023 would be worth ₹3,522 as of May 2026, representing a +252.2% total return.
What would ₹1,000 invested in LUPIN 5 years ago be worth today?
A ₹1,000 investment in Lupin Limited (LUPIN) in 2021 would be worth ₹2,246 as of May 2026, representing a +124.6% total return.
What would ₹1,000 invested in LUPIN 10 years ago be worth today?
A ₹1,000 investment in Lupin Limited (LUPIN) in 2016 would be worth ₹1,328 as of May 2026, representing a +32.8% total return.
What would ₹1,000 invested in LUPIN at IPO be worth today?
A ₹1,000 investment in Lupin Limited (LUPIN) at IPO would be worth ₹356,458 as of May 2026, representing a +35545.8% total return.
Monthly Returns Heatmap
Over the past 24+ years (294 months), Lupin Limited (LUPIN) has averaged a monthly return of +2.77% with a median return of +1.54%. The stock had 173 positive months (59%) and 121 negative months (41%). The best month in LUPIN's history was March 2004 with a +92.6% return, while the worst was September 2003 at -48.3%. Historically, April tends to be the strongest month (averaging +9.8%), and January the weakest (-1.3%).
LUPIN's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2003 with a cumulative return of +134.6%, and the worst was 2017 at -46.5%.
Annual Returns
Over 25 years of trading history, Lupin Limited (LUPIN) has delivered an average annual return of +33.86% with a median return of +28.79%. The compound annual growth rate (CAGR) is +25.66%. The stock posted gains in 16 years (64%) and losses in 9 years (36%).
LUPIN's best year was 2003 with a +144.63% gain, while the worst was 2017 at -40.08%. The longest streak of consecutive positive years was 6, and the longest losing streak was 4 years. LUPIN achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +9.74% | ₹2,109.50 | ₹2,314.90 |
| 2025 | -9.89% | ₹2,341.14 | ₹2,109.50 |
| 2024 | +78.84% | ₹1,309.03 | ₹2,341.14 |
| 2023 | +81.09% | ₹722.86 | ₹1,309.03 |
| 2022 | -22.35% | ₹930.91 | ₹722.86 |
| 2021 | -2.13% | ₹951.16 | ₹930.91 |
| 2020 | +28.79% | ₹738.56 | ₹951.16 |
| 2019 | -8.99% | ₹811.52 | ₹738.56 |
| 2018 | -4.02% | ₹845.52 | ₹811.52 |
| 2017 | -40.08% | ₹1,411.14 | ₹845.52 |
| 2016 | -18.71% | ₹1,735.89 | ₹1,411.14 |
| 2015 | +29.18% | ₹1,343.81 | ₹1,735.89 |
| 2014 | +58.19% | ₹849.47 | ₹1,343.81 |
| 2013 | +48.64% | ₹571.50 | ₹849.47 |
| 2012 | +37.87% | ₹414.54 | ₹571.50 |
| 2011 | -6.59% | ₹443.80 | ₹414.54 |
| 2010 | +64.83% | ₹269.25 | ₹443.80 |
| 2009 | +141.94% | ₹111.29 | ₹269.25 |
| 2008 | -0.42% | ₹111.76 | ₹111.29 |
| 2007 | +3.34% | ₹108.15 | ₹111.76 |
| 2006 | +61.53% | ₹66.95 | ₹108.15 |
| 2005 | +12.13% | ₹59.71 | ₹66.95 |
| 2004 | +98.19% | ₹30.13 | ₹59.71 |
| 2003 | +144.63% | ₹12.32 | ₹30.13 |
| 2002 | +60.71% | ₹7.66 | ₹12.32 |
LUPIN Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Lupin Limited as an investment
Valuation
LUPIN currently trades at a trailing P/E ratio of 22.8, which is considered moderate relative to the broader market. The forward P/E of 23.7 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 5.4. The price-to-sales ratio is 4.0.
Dividends
Lupin Limited pays a dividend to shareholders with a current yield of 0.52%. This translates to $12.00 per share annually. The payout ratio of 12% indicates sustainable dividend coverage.
Risk & Volatility
LUPIN has a beta of 0.31, indicating it is less volatile than the overall market. The stock's 52-week range is $1795.20 to $2377.60, and it currently trades near its 52-week high.
Analyst Ratings
Based on 37 analyst opinions, LUPIN has a consensus "buy" rating. The average price target of $2429.05 suggests 4.9% upside from current levels.
Frequently Asked Questions: LUPIN
What sector is LUPIN in? ▼
LUPIN operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has LUPIN performed historically? ▼
Over 25 years of trading history, LUPIN has posted gains in 16 years (64% of the time). The best year was 2003 with a +144.6% return. Past performance does not guarantee future results.
How can I invest in LUPIN? ▼
You can invest in LUPIN through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold LUPIN.
Does LUPIN pay dividends? ▼
Lupin Limited pays a dividend to shareholders with a current yield of 0.52%. This translates to $12.00 per share annually. The payout ratio of 12% indicates sustainable dividend coverage.
What does Lupin Limited do? ▼
Lupin Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India.
What sector is LUPIN in? ▼
LUPIN operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did LUPIN go public? ▼
Lupin Limited went public in 2001, making it a 25-year-old public company as of 2026.
How much would $1,000 invested in LUPIN 5 years ago be worth today? ▼
A $1,000 investment in LUPIN five years ago would be worth approximately $2,246 today, representing a 124.6% return.
Does LUPIN pay dividends? ▼
Yes, Lupin Limited pays a dividend with a current yield of 0.52%, which is $12.0 per share annually.
What is LUPIN's market cap? ▼
Lupin Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.
What is LUPIN's P/E ratio? ▼
LUPIN has a trailing P/E ratio of 22.8 and a forward P/E of 23.7, which measures how much investors are paying per dollar of earnings.
Is LUPIN a buy, hold, or sell? ▼
Based on 37 opinions, LUPIN has a consensus "buy" rating. The average price target is $2429.05.
Last updated: 3/14/2026